Their results found that RRSO is not associated with a significant reduction in the overall primary breast cancer (PBC) or contralateral breast cancer (CBC) risk in BRCA1 and BRCA2 carriers combined or in BRCA1 carriers alone. Here, BRCA1 is linked to complete blood cell count.